Bayer AG, the 154-year-old creator of aspirin, has been ambushed by a growing force: online retailers like Amazon.com Inc.
The German drugmaker’s consumer-health division is struggling, with profit plummeting 17 percent in the third quarter. A big part of the reason is a shift in the U.S. to onlin
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
Bloomberg
Nigeria's leading finance and market intelligence news report. Also home to expert opinion and commentary on politics, sports, lifestyle, and more
